Wow!..92 % reduction..
Who said Antisense Gen2 was useless...
ISIS-TTRRx is a gen 2.0+ antisense drug Isis is developing with GSK for the treatment of TTR amyloidosis. ISIS-TTRRx is administered as a once weekly subcutaneous injection and is designed to inhibit the production of all forms of TTR protein, including both mutant and wild type, offering a unique approach to treat all types of TTR amyloidosis.
Read more: http://www.nasdaq.com/press-release...-ttr-amyloidosis-20150422-01191#ixzz3Y7xnLI2R
- Forums
- ASX - By Stock
- ANP a Company in the making.
Wow!..92 % reduction.. Who said Antisense Gen2 was useless......
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.002(2.70%) |
Mkt cap ! $67.61M |
Open | High | Low | Value | Volume |
7.5¢ | 7.6¢ | 7.5¢ | $29.46K | 393.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7453 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 15846 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6819 | 0.076 |
2 | 84412 | 0.075 |
2 | 76616 | 0.074 |
2 | 111973 | 0.073 |
2 | 63400 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 15310 | 3 |
0.078 | 75476 | 2 |
0.079 | 446173 | 3 |
0.080 | 243231 | 2 |
0.081 | 100000 | 1 |
Last trade - 11.48am 07/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |